Resveratrol is produced in hudge amount in grapevine skin in response to infection by Bothrytis cinerea. This production of resveratrol blocks the proliferation of the pathogen, thereby acting as a natural antibiotic. Numerous studies have reported interesting properties of trans-resveratrol as a preventive agent against important pathologies i.e. vascular diseases, cancers, viral infection or neurodegenerative processes. Moreover, several epidemiological studies have revealed that resveratrol is probably one of the main microcomponents of wine responsible for its health benefits such as prevention of vaso-coronary diseases and cancer. Resveratrol acts on the process of carcinogenesis by affecting the three phases: tumor initiation, promotion and progression phases and suppresses the final steps of carcinogenesis, i.e. angiogenesis and metastasis. It is also able to activate apoptosis, to arrest the cell cycle or to inhibit kinase pathways. Interestingly, resveratrol does not present any cytotoxicity in animal models. Moreover, concentrations of resveratrol in blood seem to be sufficient for anti-invasive activity.
- Delmas D, Lancon A, Colin D, Jannin B, Latruffe N: Resveratrol as a chemopreventive agent: a promising molecule for fighting cancer.
Curr Drug Targets 2006, 7:423-442. PubMed Abstract | Publisher Full Text
-
Tome-Carneiro J, Gonzalvez M, Larrosa M, Yanez-Gascon
MJ, Garcia-Almagro FJ, Ruiz-Ros JA, Tomas-Barberan FA,
Garcia-Conesa MT, Espin JC: Resveratrol in primary and secondary prevention of cardiovascular disease: a dietary
and clinical perspective.
Ann N Y Acad Sci 2013, 1290:37-51. PubMed Abstract | Publisher Full Text - Virginie Aires, Dominique Delmas and al. Orphanet journal of rare diseases